Skip to main content
  • CMS considers Medicare coverage for TAVR in asymptomatic patients

    The U.S. Centers for Medicare and Medicaid Services (CMS) announced it is reconsidering Medicare coverage for the use of transcatheter aortic valve replacement (TAVR) to treat severe aortic stenosis (AS) in asymptomatic patients.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details